Abstract. The pathogenesis of Alzheimer disease (AD) involves the complex interaction between genetic and environmental factors affecting multiple cellular pathways. Recent advances in systems biology provide a system-level understanding of AD by elucidating the genome-wide molecular interactions. By using KeyMolnet, a bioinformatics tool for analyzing molecular interactions on the curated knowledgebase, we characterized molecular network of 2,883 all stages of AD-related genes (ADGs) and 559 incipient AD-related genes (IADGs) identified by global gene expression profiling of the hippocampal CA1 region of AD brains in terms of significant clinical and pathological correlations (Blalock et al., Proc Natl Acad Sci USA 101: [2173][2174][2175][2176][2177][2178] 2004). By the common upstream search, KeyMolnet identified cAMP-response element-binding protein (CREB) as the principal transcription factor exhibiting the most significant relevance to molecular networks of both ADGs and IADGs. The CREBregulated transcriptional network included upregulated and downregulated sets of ADGs and IADGs, suggesting an involvement of generalized deregulation of the CREB signaling pathway in the pathophysiology of AD, beginning at the early stage of the disease. To verify the in silico observations in vivo, we conducted immunohistochemical studies of 11 AD and 13 age-matched control brains by using anti-phoshorylated CREB (pCREB) antibody. An abnormal accumulation of pCREB imunoreactivity was identified in granules of granulovacuolar degeneration (GVD) in the hippocampal neurons of AD brains. These observations suggest that aberrant CREB-mediated gene regulation serves as a molecular biomarker of AD-related pathological processes, and support the hypothesis that sequestration of pCREB in GVD granules is in part responsible for deregulation of CREB-mediated gene expression in AD hippocampus.
Introduction
Alzheimer disease (AD) is the most common cause of dementia worldwide, affecting the elderly population, characterized by the hallmark pathology of amyloid-β (Aβ) deposition and neurofibrillary tangle (NFT) formation in the brain. The complex interac-tion between genetic and environmental factors affecting multiple cellular pathways plays a role in the pathogenesis of AD [1] . The completion of the Human Genome Project in 2003 allows us to systematically characterize the comprehensive disease-associated profiles of the whole human genome. It promotes us to identify disease-specific and stage-specific molecular signatures and biomarkers for diagnosis and prediction of prognosis, and druggable targets for therapy [2] . Actually, global transcriptome analysis of AD brains identified a battery of genes aberrantly regulated in AD, whose role has not been previously predicted in its pathogenesis. They include reduced expression of kinases/phosphatases, cytoskeletal proteins, synaptic proteins, and neurotransmitter receptors in NFT-bearing CA1 neurons [3] , downregulaton of neurotrophic factors and upregulation of proapoptotic molecules in the hippocampal CA1 region [4] , disturbed sphingolipid metabolism in various brain regions during progression of AD [5] , and overexpression of the AMPA receptor GluR2 subunit in synaptosomes of prefrontal cortex [6] . However, in global expression analysis, the important biological implications are often left behind to be characterized, because the huge amount of high-density microarray data is highly complex. Furthermore, cardinal observations obtained from in silico data analysis should be validated by independent wet lab experiments.
Recent advances in systems biology enable us to illustrate a cell-wide map of the complex molecular interactions with aid of the literature-based knowledgebase of molecular pathways [7, 8] . In the scale-free molecular network, targeted disruption of several critical components, on which the biologically important molecular connections concentrate, could disturb the whole cellular function by destabilizing the network [9] . Thus, molecular network analysis goes beyond gene-by-gene analysis to shed light on a system-level understanding of molecular relationships among individual genes and networks.
The present study is designed to conduct molecular network analysis of a published microarray dataset of Blalock et al. [10] . It contains genome-wide expression profiling of hippocampal CA1 tissues derived from 22 AD patients with well-defined clinical and pathological stages. They identified 3,413 all stages of AD-related genes (ADGs) and 609 incipient ADrelated genes (IADGs), and characterized overrepresented genes by using a bioinformatics tool named Expression Analysis Systematic Explorer (EASE). They found upregulation of tumor suppressors, oligodendrocyte growth factors, and protein kinase A (PKA) modulators, along with downregulation of protein folding/metabolism/transport machinery molecules in incipient AD (IAD) [10] . Recently, a different study followed up analysis of this dataset by weighted gene coexpression network analysis (WGCNA) that calculates a matrix containing all pairwise Pearson correlations between whole microarray probe sets across all subjects in an unsupervised manner. They identified AD-related coexpression modules that play key roles in synaptic transmission, extracellular transport, mitochondrial and metabolic functions, and myelination [11] . However, all of these studies did not clarify the common upstream transcription factors governing molecular networks, closely associated with deregulated gene expression in AD brains. By using KeyMolnet, a bioinformatics tool for analyzing molecular interactions on the curated knowledgebase [12] , we characterized the most relevant molecular network of AD brain transcriptome, composed of the genes coordinately regulated by putative common upstream transcription factors.
Materials and methods

The dataset
We performed molecular network analysis of ADGs and IADGs, derived from a dataset of Blalock et al. [10] . It contains gene expression profiling of frozen tissues of the CA1 hippocampus, performed by analyzing with the Affymetrix Human Genome HG-U133A chip that contains 22,215 transcripts. The complete dataset is available from Gene Expression Omnibus (GEO) database (GSE1297). RNA was isolated from the samples of 31 age-matched individuals, composed of nine control subjects, seven patients with incipient AD (IAD), eight with moderate AD, and seven with severe AD [10] . The dataset was normalized following the Microarray Analysis Suite 5.0 (MAS5) algorithm. The clinical stage of AD was defined by the MiniMental State Examination (MMSE) score, i.e. control (MMSE > 25), incipient AD (MMSE 20-26), moderate AD (MMSE [14] [15] [16] [17] [18] [19] , and severe AD (MMSE < 14). The neurofibrillary tangle (NFT) burden was determined in each brain sample, which always showed an inverse relationship with the MMSE score. The statistical correlation between the expression levels of individual genes and the MMSE and NFT scores was evaluated by Pearson's correlation tests and ANOVA. With respect to overall correlations across 31 subjects, the study identified 3,413 ADGs, composed of 1,977 upregulated and 1,436 downregulated genes in all stages of AD patients versus control subjects. The study also identified 609 IADGs, composed of 431 upregulated and 178 downregulated genes in IAD patients versus control subjects.
Gene ID conversion
We converted Affymetrix probe IDs into the corresponding National Center for Biotechnology Information (NCBI) Entrez Gene IDs by using the Database for Annotation, Visualization and Integrated Discovery (DAVID) 2008 Gene ID conversion tool (david.abcc.ncifcrf.gov) [13] . Then, we excluded a set of non-annotated genes, overlapping genes, and those listed concurrently in both upregulated and downregulated classes.
Molecular network analysis
KeyMolnet is a comprehensive knowledgebase, originally developed by the Institute of Medicinal Molecular Design (IMMD), Tokyo, Japan [12] . It covers virtually all the relationships heretofore reported among human genes, molecules, diseases, pathways and drugs, whose information is manually collected, carefully curated, and regularly updated by expert biologists. The database is categorized into the core contents collected from selected review articles with the highest reliability, or the secondary contents extracted from abstracts of PubMed database and Human Protein Reference database (HPRD). By importing microarray data, such as the list of Entrez Gene ID and fold changes of individual probes, KeyMolnet automatically provides corresponding molecules as a node on networks.
The common upstream search is a mode of network analysis that extracts the most relevant molecular network composed of the genes coordinately regulated by putative common upstream transcription factors. The generated network was compared side by side with 403 human canonical pathways of the KeyMolnet library. To reduce the potential bias toward the selection of major pathways, all well-established biological pathways covering both major and minor classes were collected by extensive search of valid review articles with journal impact factors greater than 10. Further information on the canonical pathways of KeyMolnet is available from IMMD upon request (www.immd.co.jp/en/keymolnet/index.html). The algorithm counting the number of overlapping molecular relations between the extracted network and the canonical pathway makes it possible to identify the canonical pathway showing the most significant contribution to the extracted network. It is constructed by modification of the algorithm developed for GO::TermFinder [14] . The significance in the similarity between the extracted network and the canonical pathway is scored following the formula, where O = the number of overlapping molecular relations between the extracted network and the canonical pathway, V = the number of molecular relations located in the extracted network, C = the number of molecular relations located in the canonical pathway, T = the number of total molecular relations composed of approximately 110,000 sets, and the X = the sigma variable that defines coincidence.
Immunohistochemistry
The autopsied brain samples were provided by Research Resource Network (RRN), Japan. Written informed consent was obtained form all the cases. The Ethics Committee of National Center of Neurology and Psychiatry approved the present study. The study population consists of 11 AD patients composed of five men and six women with the mean age of 71 ± 9 years, and 13 other neurological disease (termed as non-AD) patients composed of six men and seven women with the mean age of 69 ± 9 years. The non-AD cases include three patients with Parkinson disease (PD), two with multiple system atrophy (MSA), four with amyotrophic lateral sclerosis (ALS), and four with myotonic dystrophy. The average of brain weight was 1,038 ± 163 gram in AD cases and 1,195 ± 182 gram in non-AD cases. Brain tissues of the hippocampus and the motor cortex were fixed with 4% paraformaldehyde (PFA), embedded in paraffin, and processed for ten micron-thick serial sections. All AD cases were satisfied with the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) criteria for diagnosis of definite AD [15] . They were categorized into the stage C of amyloid deposition and the stage VI of neurofibrillary degeneration, following the Braak's staging [16] .
The immunohistochemistry protocol was described elsewhere [17] . In brief, after deparaffination, tissue sections were heated in 10 mM citrate sodium buffer, pH 6.0 by autoclave at 125
• C for 30 sec in a temperature-controlled pressure chamber (Dako, Tokyo, Japan). They were incubated with 3% hydrogen peroxide-containing methanol to block the endogenous peroxidase activity, and with phosphate-buffered saline (PBS) containing 10% normal goat serum (NGS) at room temperature (RT) for 15 min to block non-specific staining. Then, tissue sections were stained at 4
• C overnight with rabbit polyclonal anti-phoshorylated cAMP-response element-binding protein (pCREB) an-tibody at a dilution of 1:1,000 (Y011052; Applied Biological Materials, Richmond, BC, Canada). This antibody was produced against a synthesized phosphopeptide spanning R-P-SP-Y-R, derived from the human CREB1 amino acid sequences surrounding the serine 133 residue (Ser-133), and purified by affinitychromatography with an epitope-specific phosphopeptide. The specificity of the antibody was verified by western blot analysis of a human neuronal cell line exposed to forskolin in culture (not shown). After several washes, the tissue sections were incubated with horseradish peroxidase (HRP)-conjugated anti-rabbit antibody (Nichirei, Tokyo, Japan), and colorized with DAB substrate (Vector Laboratories, Burlingame, CA, USA), followed by a counterstain with hematoxylin. The adjacent sections were immunolabeled with mouse monoclonal anti-GFAP antibody (Nichirei). For negative controls, the step of incubation with primary antibodies was omitted.
Results
Transcriptome dataset of Alzheimer disease hippocampus
The dataset of Blalock et al. [10] contains genomewide transcriptome of the hippocampus CA1 region, derived from nine control subjects, seven patients with incipient AD (IAD), eight with moderate AD, and seven with severe AD. They identified 3,413 all stages of AD-related genes (ADGs) and 609 IAD-related genes (IADGs) based on significant clinical and pathological correlations. We performed extensive curation of their data, and extracted 2,883 Entrez Gene IDs of ADGs, composed of 1,675 upregulated and 1,208 downregulated genes in all stages of AD patients versus control subjects (Supplementary Tables 1 and 2 online) . We also identified 559 Entrez Gene IDs of IADGs, composed of 395 upregulated and 164 downregulated genes in IAD patients versus control subjects (Supplementary  Tables 3 and 4 
online).
The molecular network analysis of ADGs and IADGs identified CREB as a central transcription factor
First, we imported 2,883 Entrez Gene IDs of ADGs, along with the expression levels, into KeyMolnet (the version 4.9.9.616 of July 1, 2009). The common upstream search of the core contents generated a complex network composed of 508 fundamental nodes with 735 molecular relations, arranged with respect to subcellular location of the molecules by the editing function of KeyMolnet (Fig. 1) . By statistical evaluation, the extracted network showed the most significant relationship with transcriptional regulation by CREB with the score of 229 and score (p) = 1.141E-069, where CREB is located as a common upstream transcription factor that has direct connections with 50 nodes, all of which are known CRE-responsive genes ( Fig. 2 and Table 1 ). Unexpectedly, the CREB-regulated transcriptional network is comprised of not only 17 upregulated ADGs but also 26 downregulated ADGs. These results suggest not simply either overactivation or hypoactivation of CREB but an involvement of generalized deregulation of the CREB signaling pathway in the pathophysiology of AD. The second rank pathway was transcriptional regulation by nuclear factor kappa B (NF-κB) with the score of 158 and score (p) = 1.945E-048 ( Supplementary Fig. 1 online) , while the third rank was transcriptional regulation by vitamin D receptor (VDR) with the score of 140 and score (p) = 5.841E-042 ( Supplementary Fig. 2 online) .
Next, we imported 559 Entrez Gene IDs of IADGs and the expression levels into KeyMolnet. Subsequently, the common upstream search of the core contents generated a less complex network composed of 143 fundamental nodes with 190 molecular relations (Fig. 3) . By statistical evaluation, the extracted network showed again the most significant relationship with transcriptional regulation by CREB with the score of 71 and score (p) = 3.325E-022, comprised of 5 upregulated and 5 downregulated IADGs (Fig. 4 and Table 1). These results suggest that functional impairment of CREB in the AD hippocampus is beginning at the early stage of the disease. The second rank pathway was transcriptional regulation by NF-κB or by glucocorticoid receptor (GR) with the identical score of 53 and score (p) = 1.163E-016 between both.
Granulovacuolar degeneration in hippocampal neurons of AD brains expressed pCREB immunoreactivity
It is well known that a wide range of extracellular stimuli activates CREB by inducing phosphorylation of Ser-133 on CREB, thereby it functions as a transcriptional activator [18, 19] . Because the molecular network of both ADGs and IADGs reflects persistent impairment of CREB function in the AD hippocampus, we studied the expression of Ser-133-phosphorylated Km represents additional nodes unlisted in the original set of 2,883 ADGs but automatically incorporated from KeyMolnet core contents following the network-searching algorithm.
CREB (pCREB) in 11 AD and 13 age-matched control brains by immunohistochemistry. The granular components of granulovacuolar degeneration (GVD), accumulated in the cytoplasm of hippocampal pyramidal neurons in both AD and non-AD brains, expressed strong immunoreactivity against pCREB (Fig. 5 , panels a-d). However, the nuclei of hippocampal pyramidal neurons were devoid of pCREB immunoreac- tivity. In addition, the vacuolar component of GVD lacked pCREB immunoreactivity, while neuritic processes of hippocampal neurons expressed variable levels of pCREB immunoreactivity (Fig. 5, panel c) . pCREB-immunoreactive GVD-bearing neurons were distributed chiefly in the CA1-CA3 sectors. Senile plaques and neurofibrillary tangles were completely devoid of pCREB immunolabeling. Although the number of pCREB-immunoreactive GVD-bearing neurons was varied among the cases, it was significantly greater in the hippocampus of AD compared with non-AD (p = 0.00020 by Mann-Whiteney's U test) (Fig. 6) . pCREB-immunoreactive GVD-bearing neurons were occasionally found in the CA4 and subicular regions of AD brains, but barely detectable in the corresponding regions of non-AD brains. In both AD and non-AD brains, substantial numbers of neuronal axons distributed in the white matter of the motor cortex expressed intense pCREB immunoreactivity (Fig. 5 , panel e). In both AD and non-AD brains, a subpopulation of reactive astrocytes and almost all ependymal cells expressed strong pCREB immunoreactivity, but it was located predominantly in their nuclei (Fig. 5 , panel f). In both AD and non-AD brains, most neurons except for hippocampal pyramidal neurons did not express discernible pCREB immunoreactivity in their cell bodies and nuclei. Neither oligodendrocytes nor microglia expressed pCREB immunoreactivity in any cases examined.
Discussion
Since microarray analysis usually produces a large amount of gene expression data at one time, it is often difficult to find out the meaningful relationship be- Fig. 2 . The CREB-regulated transcriptional network of ADGs. The CREB-regulated transcriptional network extracted from the ADG network of Fig. 1 consists of a central node of CREB and 50 connecting nodes of CREB target genes listed in Table 1. tween gene expression profile and biological implications from such a large quantity of available data. To overcome this difficulty, we have made a breakthrough to identify the molecular network most closely associated with microarray data by using a novel bioinformatics tool named KeyMolnet [12] . KeyMolnet includes the highly reliable information on a wide range of human proteins, small molecules, molecular relations, diseases, and drugs. All the contents are manually collected and carefully curated by experts from the literature and public databases. The application of KeyMolnet has an advantage that the user can easily merge microarray data with the comprehensive knowledgebase to characterize pathophysiologically meaningful networks from the high-throughput gene expression data [20, 21] . In particular, the common upstream search is the most powerful approach to identify a battery of common transcription factors governing molecular networks closely associated with aberrant gene expression. By using KeyMolnet, we characterized the molecular network of 2,883 ADGs and 559 IADGs that show significant correlations with MMSE score and NFT burden in either all stages of AD or the early stage of AD [10] . We identified CREB as the central transcription factor that exhibits the most significant relevance to molecular networks of both ADGs and IADGs.
CREB is the prototype stimulus-inducible transcription factor binding as a dimer to a conserved cAMPresponsive element (CRE) of the target genes [18, 19] . CREB is promptly activated in response to a wide range of extracellular stimuli, such as growth factors, peptide hormones, and neuronal activity, all of which activate various protein kinases such as PKA, mitogen-activated protein kinases (MAPKs), and Ca 2+ /calmodulindependent protein kinases (CAMKs). They phosphorylate Ser-133 located in the KID domain of CREB. The phosphorylation of Ser-133 on CREB (pCREB) induces the recruitment of a transcriptional coactivator named CREB binding protein (CBP), thereby activates the expression of CRE-responsive genes. The CREB target genes play key roles in neuronal devel- opment, synaptic plasticity, and neuroprotection in the central nervous system (CNS). Currently, we are able to search thousands of CREB target genes via the webaccessible database (natural.salk.edu/CREB) [22] . In the present study, the CREB-regulated transcriptional network consisted of both upregulated and downregulated sets of ADGs and IADGs. These observations suggest not simply either overactivation or hypoactivation of CREB but an involvement of generalized deregulation of the CREB signaling pathway in the pathophysiology of AD, emerging at the early stage of the disease.
To verify the in silico observations in vivo, we conducted immunohistochemical studies of 11 AD and 13 age-matched non-AD control brains by using antipCREB antibody. We identified aberrant pCREB immunoreactivity concentrated in granules of GVD in the hippocampus of both AD and non-AD brains,where the number of pCREB-immunoreactive GVD-bearing neurons was significantly greater in AD than non-AD cases. These results suggest that pCREB-immunoreactive GVD does not itself serve as an AD-specific diagnostic marker. However, these observations would support the hypothesis that sequestration of pCREB in GVD granules might be in part attributable to disturbed CREBregulated gene expression in AD hippocampus.
Physiologically, CREB plays a pivotal role in the long-term memory formation in CA1 hippocampal neurons [23] . A previous study by western blot analysis showed that pCREB levels are reduced in AD brain tissues, although the cellular and subcellular location of pCREB was not characterized [24] . In a rat model, cortical impact injury induces a cognitive impairment, associated with reduced expression of CREB and target genes in the ipsilateral hippocampus [25] . A phosphodiesterase-4 inhibitor rolipram, by activating the cAMP/PKA/CREB signaling pathway, ameliorates deficits in long-term potential and cognitive function Table 1. in a transgenic mouse model of AD [26] . Overactivation of calpain induces proteolysis of PKA subunits, resulting in inactivation of CREB in AD brains [27] . High levels of intracellular Aβ induce sustained hyperphosphorylation of CREB that blocks nuclear translocation of pCREB, resulting in inactivation of CREBregulated gene expression [28] . The Aβ oligomers inactivate MAPKs, PKA, and cyclic GMP-dependent protein kinase essential for CREB activation in hippocampal neurons [29] [30] [31] . Long-term treatment with green tea catechin reduces the levels of Aβ oligomers, thereby restores the expression of CREB target genes, such as BDNF and PSD95, in the hippocampus [32] . All of these observations support a possible scenario that a defect in the CREB-mediated signaling pathway in hippocampal neurons causes cognitive disturbance during progression of AD. Therefore, CREB serves as a promising molecular target for treatment of dementia in AD [33] .
The accumulation of misfolded cellular proteins within neurons, due to a defect in the clearance system, such as the ubiquitin-proteasome system (UPS) and the autophagic-lysosomal system, is a pathological hallmark of various neurodegenerative diseases [34] . Degradation of CREB involves nuclear export of CREB, modification by polyubiquitination, and processing for proteasomes, suggesting that UPS is a major system for CREB degradation under normal physiological conditions [35, 36] . We identified an abnormal accumulation of pCREB in GVD granules of hippocampal neurons in AD brains. GVD is a pathological change characterized by electron-dense granules within double membrane-bound cytoplasmic vacuoles that highly resemble autophagosomes [37] . The emergence of GVD is confined to hippocampal pyramidal neurons of AD brains, and infrequently found in those of other neurodegenerative diseases. GVD is barely detectable in other brain regions. It plays a role in sequestration and degradation of unnecessary proteins and organelles in neurons exposed to aging-related stressful insults [37] . The active forms of caspase-3, glycogen synthase kinase-3β (GSK-3β), c-Jun N-terminal kinase (JNK), c-Jun, pancreatic eIF2-alpha kinase (PERK), and TAR DNA-binding protein-43 (TDP-43), all of which are modified by phosphorylation, are found to be accumulated in GVD granules of hippocampal neurons in AD brains [38] [39] [40] [41] [42] [43] . GVD granules also include cytoskeletal proteins, such as neurofilament, tubulin, and tau, along with ubiquitin [44, 45] . At present, the precise implication of pCREB accumulation in GVD granules of hippocampal neurons in AD brains remains unknown. Importantly, degenerating neurons but not apparently healthy neurons in AD brains exhibit the profuse accumulation of autophagic vacuoles (AVs), owing to decreased clearance of AVs [46] , suggesting an involvement of impaired autophagy function in formation of pCREB-accumulated GVD granules.
We found that neuronal axons, neuritic processes, and a subpopulation of reactive astrocytes also express pCREB immunoreactivity in both AD and non-AD brains. In a rat model of neuronal injury, reactive astrocytes express pCREB following intracerebroventricular injection of kinate [47] . In developing mouse DRG neurons, CREB protein is translated in response to NGF from the corresponding mRNA located in axons, and subsequently translocated to the cell body via a retro-p = 0.00020 Fig. 6 . The number of pCREB-immunoreactive GVD-bearing neurons in the hippocampus of AD and non-AD brains. The number of pCREB-immunoreactive GVD-bearing neurons was counted in the CA1, CA2, CA3 and CA4 sectors and the subiculum of the hippocampus, derived from 11 AD cases and 13 age and sex-matched other neurological disease (non-AD) cases. Non-AD cases include three patients with Parkinson disease (PD), two with multiple system atrophy (MSA), four with amyotrophic lateral sclerosis (ALS), and four with myotonic dystrophy. The total number in each case is plotted. The statistical difference in the numbers between AD and non-AD was evaluated by Mann-Whitney's U test.
grade axonal transport [48] . These observations would provide an explanation for glial or axonal location of CREB and pCREB.
We identified NF-κB-regulated gene expression as the second significant pathway in the molecular network of AGDs and IADGs ( Supplementary Fig. 1  online) . The NF-κB family, consisting of NF-κB1 (p50/p105), NF-κB2 (p52/p100), RelA (p65), RelB, and c-Rel, acts as a central regulator of innate and adaptive immune responses, cell proliferation, and apoptosis [49] . Under unstimulated conditions, NF-κB is sequestrated in the cytoplasm via non-covalent interaction with the inhibitor of NF-κB (IκB). Proinflammatory cytokines and stress-inducing agents activate specific IκB kinases that phosphorylate IκB proteins. Phosphorylated IκBs are ubiquitinated, and then processed for proteasome-mediated degradation, resulting in nuclear translocation of NF-κB that regulates the expression of hundreds of target genes by binding to the consensus sequence located in the promoter. Importantly, the expression of NF-κB p65 is enhanced in neurons, NFTs, and dystrophic neurites in the hippocampus and entorhinal cortex of AD brains [50] . A NF-κB-inducible microRNA, MiR-146a, reduces the expression of complement factor H (CFH), a negative regulator of proinflammatory responses in AD brains [51] .
We also identified gene expression regulated by vitamin D receptor (VDR) as the third significant pathway in the molecular network of AGDs (Supplementary Fig. 2 online) . Vitamin D plays a neuroprotective role by modulating neuronal calcium homeostasis. By forming a heterodimer with the retinoid X receptor (RXR), VDR activates the transcription of target genes with the vitamin D response element (VDRE) in the promoter. A significant association is found between VDR gene polymorphism and development of AD [52] . In AD brains, the expression of VDR and its target calbindin D28K is downregulated in hippocampal CA1 neurons [53] .
In conclusion, KeyMolnet has effectively characterized molecular network of 2,883 ADGs and 559 IADGs. The common upstream search identified CREB as the principal transcription factor that regulates molecular networks of both ADGs and IADGs. Im-munohistochemical study showed an abnormal accumulation of pCREB in GVD granules in hippocampal neurons of AD brains. These observations suggest that aberrant CREB-mediated gene regulation serves as a molecular biomarker of AD-related pathological processes, and support the hypothesis that sequestration of pCREB in GVD granules is in part responsible for deregulation of CREB-mediated gene expression in AD hippocampus.
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